SCHEMBL20733715

SCHEMBL20733715

c1ccc(-c2ccc3c(c2)c2cc(-c4ccccc4)ccc2c2nc(-c4ccccc4)nnc32)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 2/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ ALDH1A1 P00352 2/20 0.40
▸ MAPT P10636 2/20 0.40
▸ DHFR P00374 1/20 0.39
▸ ESR1 P03372 2/20 0.38
▸ ESR2 Q92731 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ BACE1 P56817 1/20 0.38
▸ JAK2 O60674 2/20 0.37
▸ NFKB1 P19838 1/20 0.37
▸ NFKB2 Q00653 1/20 0.37
▸ RELA Q04206 1/20 0.37
▸ TRIM58 Q8NG06 1/20 0.36
▸ KDM4C Q9H3R0 1/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ NTSR1 P30989 1/20 0.36
▸ HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20733799 0.93 ALDH1A1 (0.40) NPC1RAB9AMAPK1ALDH1A1MAPT
SCHEMBL20733721 0.92 GP6 (0.40) NPC1RAB9AMAPK1ALDH1A1MAPT
SCHEMBL20733712 0.92 MEN1 (0.40) NPC1RAB9AMAPK1ALDH1A1MAPT
SCHEMBL30259088 0.81 ALDH1A1 (0.39) ALDH1A1MAPTDHFRESR1ESR2
SCHEMBL20721644 0.81 ALDH1A1 (0.39) ALDH1A1MAPTDHFRESR1ESR2
SCHEMBL20733785 0.80 CYP1A2 (0.41) NPC1RAB9AMAPTDHFRSMN1; SMN2
SCHEMBL20733790 0.78 ALDH1A1 (0.41) NPC1RAB9AALDH1A1MAPTDHFR
SCHEMBL20733789 0.78 ALDH1A1 (0.41) NPC1RAB9AALDH1A1MAPTDHFR
SCHEMBL17343974 0.77 MEN1 (0.52) NPC1RAB9AMAPK1ALDH1A1MAPT
SCHEMBL22751780 0.76 MEN1 (0.50) NPC1RAB9AMAPK1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230057590-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2023-02-23 — — US disclosed
US-20190051842-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2019-02-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230057590-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, OXER1 NPC1 1206/4885RAB9A 2642/4885MAPK1 3206/4885
US-20190051842-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, OXER1 NPC1 1206/4885RAB9A 2642/4885MAPK1 3206/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback